Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ASCO Annual Meeting 2026 · Chicago, IL
8 shown of 6,603 total abstracts
  1. Abstract 61122026-06-01 · 20:45 CT · Hall B1
    Long-term follow-up of Opdivo adjuvant for RCC: CheckMate-936
    S. Peters, L. Paz-Ares, S. Antonia · Chinese University of Hong Kong
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  2. Abstract 63952026-06-02 · 13:30 CT · S100A
    Biomarker subgroup analysis of Keytruda in RCC (the KEYNOTE-420 study)
    N. Rizvi, A. Spira · Peter MacCallum Cancer Centre
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  3. Abstract 64182026-06-04 · 21:45 CT · Hall B1
    CheckMate-216: Opdivo (nivolumab) adjuvant in RCC
    E. Winer, F. Andre, L. Paz-Ares, et al. · National Cancer Center Japan
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  4. Abstract 69752026-06-02 · 13:45 CT · S406
    Keytruda plus chemotherapy in previously untreated RCC: updated analysis from KEYNOTE-271
    N. Rizvi, M. Reck, L. Paz-Ares, et al. · Stanford Cancer Institute
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  5. Abstract 64972026-06-02 · 13:15 CT · E450
    Long-term follow-up of Opdivo neoadjuvant for RCC: CheckMate-690
    L. Paz-Ares, A. Spira, S. Antonia · Cleveland Clinic
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  6. Abstract 68912026-06-03 · 13:15 CT · E450
    Quality of life outcomes with Opdivo in patients with RCC
    S. Peters, A. Spira · Johns Hopkins Kimmel Cancer Center
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  7. Abstract 65822026-06-04 · 20:30 CT · S100A
    Keytruda plus chemotherapy in previously untreated RCC: updated analysis from KEYNOTE-911
    M.C. Garassino, T. Mok, S. Modi, et al. · Dana-Farber Cancer Institute
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  8. Abstract 66092026-06-02 · 19:45 CT · S406
    Real-world effectiveness of Keytruda vs standard of care in RCC
    P. Schmid, T. Mok, S. Tolaney, et al. · Karolinska Institute
    Education SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.